Physician profile
Lesley Mueller
NPI 1194436105
$863.85
in general payments reported to CMS, 2019-2025
18 companies · $327 in 2025
The $327 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $537 · 2025: $327.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $864.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $863.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Incyte Corporation | $266.99 | 2025 | Opzelura, Opzelura |
| Astrazeneca Pharmaceuticals LP | $138.96 | 2024 | Airsupra, Breztri, Farxiga |
| Novartis Pharmaceuticals Corporation | $70.27 | 2024 | |
| Abbvie INC. | $57.89 | 2024 | |
| Pfizer INC. | $50.05 | 2024 | |
| Corcept Therapeutics | $35.91 | 2024-2025 | Korlym |
| Dexcom, INC. | $35.79 | 2024 | Dexcom G6 Transmitter |
| Galderma Laboratories, L.P. | $28.27 | 2025 | Aklief |
| Boehringer Ingelheim Pharmaceuticals, INC. | $25.82 | 2024 | Jardiance |
| Exact Sciences Corporation | $22.79 | 2024 | Cologuard Collection Kit |
| Vertex Pharmaceuticals Incorporated | $22.75 | 2024 | |
| Glaxosmithkline, LLC. | $22.18 | 2024 | Arexvy, Trelegy Ellipta |
| Antares Pharma, INC. | $16.20 | 2024 | Xyosted |
| Lilly USA, LLC | $16.12 | 2024 | Jardiance |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $14.53 | 2024 | Rexulti |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $13.80 | 2024 | Rybelsus, Ozempic |
| Shield Therapeutics INC | $13.39 | 2024 | |
| Biowound Solutions, INC. | $12.14 | 2025 | Bio-Connekt |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lesley Mueller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.